Titan Biotech Ltd — Important, 04-05-2026: Company Update

Titan Biotech's Annual Secretarial Compliance Report for the financial year ended March 31, 2026, confirms the company's strong adherence to applicable corporate governance and SEBI regulations. The report highlights compliance with Secretarial Standards, timely policy updates, proper website disclosures, and audit committee approval for all related party transactions. No non-compliances or actions by SEBI or Stock Exchanges were noted. This indicates robust operational and disclosure practices, signaling stability in the company's governance framework, which is positive for investors.